5.17BMarket Cap30.65P/E (TTM)
7.690High7.540Low396.10KVolume7.650Open7.850Pre Close3.01MTurnover0.07%Turnover Ratio81.72P/E (Static)679.63MShares9.96052wk High0.94P/B4.36BFloat Cap5.30052wk Low--Dividend TTM573.56MShs Float24.895Historical High--Div YieldTTM1.91%Amplitude3.642Historical Low7.604Avg Price1Lot Size
Grifols Stock Forum
Benzinga· 3 mins ago
FDA Approves Expanded Label For Grifols' XEMBIFY, The First 20% SCIg For Treatment-Naïve Patients With Primary Humoral Immunodeficiencies; Approval Includes Biweekly Dosing Following Positive Phase 4 Data, Enhancing Flexibility And Convenience For Patients
Welcome to the end of the dog days of summer for a while; my name is Kevin Travers, and here are stories from the moomoo herd on Wall Street today.
$Intel (INTC.US)$ traded higher after the firm said it had bypassed Vietnam for a $3.3B project and in...
2. $Inspire Veterinary Partners (IVP.US)$
3. $Dynatronics (DYNT.US)$
4. $Zapp Electric Vehicles (ZAPP.US)$
5. $Maxeon Solar Technologies (MAXN.US)$
6. $Grifols (GRFS.US)$
7. $SinglePoint (SING.US)$
8. $Venus Concept (VERO.US)$
9. $IDEAYA Biosciences (IDYA.US)$
10. $Kuke Music (KUKE.US)$
- Reuters
Benzinga· 1 min ago
No comment yet